At ONEtoONE, we advance the future of global wellness by connecting healthcare innovators and providers with international investment networks. Our expertise spans the entire healthcare and life sciences value chain, guiding clients through the intricacies of clinical breakthroughs, digital health integration, and complex regulatory landscapes. By leveraging our deep understanding of patient outcomes and a global pool of strategic partners, we craft tailored exit and growth strategies that address the unique challenges of modern medicine and the evolving demands of a health-conscious society.
We specialise in:
Healthcare’s inelastic demand makes it a safe-haven sector. Essential services generate stable, recurring revenue, attracting investors seeking resilience and long-term capital preservation.
Healthcare services are highly fragmented, creating opportunities for buy-and-build strategies. Firms consolidate smaller practices and labs to gain scale, streamline operations, and strengthen negotiating power with insurers.
Pharma and medtech firms use M&A as outsourced R&D, acquiring biotech companies with promising pipelines or IP. This “inorganic growth” helps replace revenues as patents expire and generics increase competition.
M&A in healthcare is surging to integrate digital tools like telemedicine, AI diagnostics, and remote monitoring. These deals boost efficiency, improve outcomes, and enable scalable care beyond physical facilities.
